Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Prognosis"" wg kryterium: Temat


Starter badań:

Tytuł :
[END-OF-LIFE PROGNOSTICATION IN ACUTE HOSPITAL PALLIATIVE PATIENTS: IS THE PALLIATIVE PERFORMANCE SCALE USEFUL?]
Autorzy :
Cohen K; Palliative Care Service, Emek Medical Center. Afula, Israel.
Paz E; Intensive Care and Palliative Care, PC Service, Emek Medical Center. Afula, Israel.
Pokaż więcej
Źródło :
Harefuah [Harefuah] 2022 May; Vol. 161 (5), pp. 304-310.
Typ publikacji :
Journal Article
MeSH Terms :
Palliative Care*
Prognosis*
Death ; Hospitals ; Humans ; Neoplasms ; Retrospective Studies
Czasopismo naukowe
Tytuł :
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies.
Autorzy :
Foroutan F; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada. Electronic address: .
Guyatt G; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Trivella M; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Kreuzberger N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Skoetz N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Riley RD; School of Medicine, Keele University, Keele, United Kingdom.
Roshanov PS; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK.
Alba AC; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada.
Sekercioglu N; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Canelo-Aybar C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Iberoamerican Cochrane Centre - Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025 Barcelona, Spain.
Munn Z; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Brignardello-Petersen R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2022 Mar; Vol. 143, pp. 202-211. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Calibration ; Forecasting ; Humans ; Probability
Czasopismo naukowe
Tytuł :
The prognostic significance of pleomorphism in gastrointestinal stromal tumours.
Autorzy :
Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Histopathology [Histopathology] 2022 Feb; Vol. 80 (3), pp. 598-603. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Biomarkers, Tumor/*genetics
Gastrointestinal Stromal Tumors/*genetics
Intestine, Small/*pathology
Mutation/*genetics
Stomach Neoplasms/*pathology
Female ; Humans ; Immunohistochemistry ; Longitudinal Studies ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
Autorzy :
Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: .
Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand.
Christie D; Genesis Care, Tugun, Qld, Australia.
Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia.
Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia.
Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Matthews J; Auckland City Hospital, Auckland, New Zealand.
Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
Spry NA; Genesis Care, Perth, WA, Australia.
Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia.
Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Pokaż więcej
Źródło :
Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 49-54. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Adenocarcinoma/*pathology
Prostatic Neoplasms/*pathology
Biopsy, Large-Core Needle ; Humans ; Male ; Neoplasm Grading/methods ; Prostate/pathology ; Prostatectomy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Probing patterns for prognostic potential.
Autorzy :
Levine SM; Department of Psychology, LMU Munich, Leopoldstraße 13, 80802, Munich, Germany. .; NeuroImaging Core Unit Munich (NICUM), University Hospital LMU, Nußbaumstraße 7, 80336, Munich, Germany. .
Pokaż więcej
Źródło :
Translational psychiatry [Transl Psychiatry] 2022 Apr 21; Vol. 12 (1), pp. 167. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prognosis*
Opinia redakcyjna
Tytuł :
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.
Autorzy :
Schneider MA; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Richtmann S; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Gründing AR; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Wrenger S; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Welte T; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Meister M; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Kriegsmann M; Translational Research Center Heidelberg (TLRC), Member of The German Center for Lung Research (DZL), D-69120 Heidelberg, Germany.
Winter H; Translational Research Center Heidelberg (TLRC), Member of The German Center for Lung Research (DZL), D-69120 Heidelberg, Germany.
Muley T; Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, D-69126 Heidelberg, Germany.
Janciauskiene S; Department of Respiratory Medicine, Hannover Medical School, D-30625 Hannover, Germany.
Pokaż więcej
Źródło :
International journal of oncology [Int J Oncol] 2022 Apr; Vol. 60 (4). Date of Electronic Publication: 2022 Feb 25.
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Adenocarcinoma of Lung/*diagnosis
Serine Endopeptidases/*analysis
Adenocarcinoma of Lung/blood ; Adenocarcinoma of Lung/genetics ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Cell Line, Tumor ; Humans ; Serine Endopeptidases/blood
Czasopismo naukowe
Tytuł :
Volumetric Splenomegaly in Patients With Polycythemia Vera.
Autorzy :
Lee MW; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yeon SH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Ryu H; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yun HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee JE; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Shin KS; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea. .
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2022 Mar 21; Vol. 37 (11), pp. e87. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :
Journal Article
MeSH Terms :
Predictive Value of Tests*
Prognosis*
Polycythemia Vera/*complications
Splenomegaly/*diagnosis
Splenomegaly/*etiology
Splenomegaly/*physiopathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Republic of Korea ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Autorzy :
Pan XQ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Huang W; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jin LW; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lin HZ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xu XY; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Mar 09; Vol. 2022, pp. 8093837. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Profiling*
Prognosis*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Pyroptosis/*genetics
Computational Biology ; Databases, Genetic ; Female ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Transcriptome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Autorzy :
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Jiang S; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Sun H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Shi B; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Li Y; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhou N; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhang D; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Mar 08; Vol. 2022, pp. 9443407. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Receptors, Interleukin*
Transcriptome*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Cell Line, Tumor ; Computational Biology ; Humans ; Survival Analysis ; Tumor Microenvironment ; Up-Regulation
Czasopismo naukowe
Tytuł :
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Autorzy :
Reig M; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Forner A; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain.
Rimola J; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ferrer-Fàbrega J; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Burrel M; BCLC Group, Vascular Department, CDI, Hospital Clinic of Barcelona, Barcelona University, University of Barcelona, Barcelona, Spain.
Garcia-Criado Á; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Galle PR; Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany.
Mazzaferro V; Department of Oncology, University of Milan and HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Salem R; Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL, USA.
Sangro B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain.
Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vogel A; Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany.
Fuster J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ayuso C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Bruix J; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Pokaż więcej
Źródło :
Journal of hepatology [J Hepatol] 2022 Mar; Vol. 76 (3), pp. 681-693. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Prognosis*
Carcinoma, Hepatocellular/*classification
Carcinoma, Hepatocellular/complications ; Female ; Humans ; Liver Neoplasms/classification ; Liver Neoplasms/complications ; Male ; Middle Aged ; Neoplasm Staging/methods ; Neoplasm Staging/statistics & numerical data ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.
Autorzy :
Xu J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Chen W; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Sun Z; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Peng H; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Zhou C; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Pan S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 24; Vol. 2022, pp. 5470166. Date of Electronic Publication: 2022 Feb 24 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/pathology
Prognosis*
Cell-Free Nucleic Acids/*genetics
DNA Copy Number Variations/*genetics
Mutation/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Middle Aged ; Mucin-1
Czasopismo naukowe
Tytuł :
Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Autorzy :
Zhao S; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.; School of Clinical Medicine, The Guizhou Medical University, Guiyang, Guizhou, China.
Jiang H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Liu J; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li DY; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li B; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Long QR; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zheng L; Shenzhen Eye Hospital, Shenzhen, 5180403 Guangdong, China.
Gu H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 23; Vol. 2022, pp. 5994800. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Disease-Free Survival*
Prognosis*
Enhancer Elements, Genetic/*genetics
Melanoma/*genetics
Uveal Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Nerve Tissue Proteins
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer.
Autorzy :
Wang QQ; School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China.
Wei Y; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Luo LP; Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Li X; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Jiang WJ; Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 22; Vol. 2022, pp. 4952812. Date of Electronic Publication: 2022 Feb 22 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
GABA Plasma Membrane Transport Proteins*
Prognosis*
Signal Transduction*
Survival Rate*
Colorectal Neoplasms/*genetics
DNA Repair/*genetics
Databases, Genetic/statistics & numerical data ; Down-Regulation ; Female ; Humans ; Male ; Phosphatidylinositol 3-Kinases/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł :
Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis.
Autorzy :
Cao P; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Li F; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Xiao Y; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Hu S; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Kong K; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Han P; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Yue J; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Deng Y; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Zhao Z; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Wu D; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, Hubei Province, China 430030.
Zhao B; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 21; Vol. 2022, pp. 5118444. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/mortality
Epigenesis, Genetic*
Lung Neoplasms*/genetics
Lung Neoplasms*/mortality
Prognosis*
Survival Rate*
RNA, Long Noncoding/*genetics
Female ; Gene Expression Profiling ; Humans ; Male ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma.
Autorzy :
Li F; Department of Oncology, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Wan B; Physical Examination Center, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Li XQ; Department of Oncology, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 11; Vol. 2022, pp. 9644466. Date of Electronic Publication: 2022 Feb 11 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Prognosis*
Transcriptome*
Adenocarcinoma of Lung/*genetics
Biomarkers, Tumor/*genetics
Lung Neoplasms/*genetics
Cadherins ; Humans
Czasopismo naukowe
Tytuł :
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Autorzy :
Lv J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Ren J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Zheng J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Zhang F; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Han M; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Pokaż więcej
Źródło :
Disease markers [Dis Markers] 2022 Feb 10; Vol. 2022, pp. 5621441. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Databases, Genetic*
Gene Expression Profiling*
Prognosis*
Tumor Microenvironment*/genetics
Tumor Microenvironment*/immunology
Breast Neoplasms/*genetics
Aged ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Female ; Genes, p53 ; Humans ; Immunotherapy ; Middle Aged ; Mutation/genetics ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
Autorzy :
Zhong F; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China.
Yao F; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Cheng Y; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Liu J; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Zhang N; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Li S; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Li M; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Huang B; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China. .; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China. .
Wang X; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China. .; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Feb 02; Vol. 12 (1), pp. 1759. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/immunology
Leukemia, Myeloid, Acute*/pathology
Leukemia, Myeloid, Acute*/therapy
Prognosis*
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Computational Biology/methods ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Immunotherapy ; Methyltransferases/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Key Aspects of Prognostic Model Development and Interpretation From a Clinical Perspective.
Autorzy :
Hoesseini A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Leeuwen N; Center for Medical Decision Making, Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.
Sewnaik A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Steyerberg EW; Center for Medical Decision Making, Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Lingsma HF; Center for Medical Decision Making, Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.
Offerman MPJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2022 Feb 01; Vol. 148 (2), pp. 180-186.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Decision-Making*
Models, Theoretical*
Prognosis*
Clinical Coding ; Decision Support Techniques ; Humans ; Predictive Value of Tests ; Risk Assessment/methods
Czasopismo naukowe
Tytuł :
Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
Autorzy :
Lee W; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA.
Law T; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA.
Lu Y; Department of Population Health and Disease Prevention, Program in Public Health, University of California Irvine, CA, USA.
Lee TK; NeoGenomics Laboratories Inc., Aliso Viejo, CA, USA.
Ibarra JA; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA; MemorialCare Orange Coast Medical Center, Fountain Valley, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 43-48. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/diagnosis
Carcinoma, Ductal, Breast*/pathology
Prognosis*
Biopsy, Large-Core Needle ; Breast/pathology ; Female ; Humans ; Mitosis ; Neoplasm Grading
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies